Pharmacovigilance and Pharmacoepidemiology (ISSN: 2638-8235)
Editor
Biography
Dr. Rizvi pursued an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent). Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. DSouza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization. Moreover, Dr. Rizvi pursued part time postdoctoral research in the laboratory of Dr. Fredric M. Menger (Charles Howard Candler Professor) at the Sanford S. Atwood Chemistry Center, Emory University, where he polished his skills in Organic Synthesis, Soft Material Chemistry, Surface and Interfacial Sciences, Gene Transfection Studies using Gemini Surfactants, State of the art, Langmuir-Adam Balance Studies. Dr. Rizvi has published many peer-reviewed articles (cited over 900 times) in top ranking journals and two book chapters. Dr. Rizvi publications include one of the most highly rated article, two cover articles and one figure from Dr. Rizvi’s paper was included in the text book Quantitative Chemical Analysis by Daniel C. Harris (7th Edition, p 616, W. H. Freeman, 2006, ISBN-10: 0716770415). Dr. Rizvi also presented his work through posters and oral presentations in national and international conferences. Dr. Rizvi also serves as editor-in-chief, the editorial board member of 33 journals and review papers for more than 72 different scientific journals. Dr. Rizvi enjoys teaching and engaging students in thought process, beside creative cooking at home and practicing martial arts.
Research Interest
Pharmaceutical formulations (direct compressed tablets, topical and liquid); Ionic liquid formation and cocrystallization of the pharmaceutical compounds; Nano and micro-encapsulation of the drugs for targeting and controlled release; Multistep synthesis of small organic molecules; Pharmaceutical analysis (forensics and method development); Design and synthesis of novel monomeric and polymeric surfactants for separation of chiral and achiral compounds in micellar electrokinetic chromatography (MEKC); Method development and validation for separations of achiral and chiral compounds utilizing MEKC-UV/MS and HPLC-UV-MS; Application of cryogenic high resolution scanning electron microscopy (Cryo-HRSEM) and analytical ultracentrifuge for characterization of polymeric surfactants; Chemical transformation of pharmacologically active compounds using microbial whole cultures; Isolation and pharmacology of compounds from fungal metabolites and medicinal plants.
Keywords
- Pharmacokinetics
- Pharmacovigilance
- Pharmaoepidemiology
- Drug discovery
- Adverse drug reaction
- Clinical pharmaoclogy
- Environmental pharmacology
- Clinical trials
- Clinical data management
- Regulatory affairs
- Pharmacodynamics
- Quality control
- Biopharmaceutical drug
- Drug development
- Generic drug
- Phamacotherapy
- Hematology
- Pathophysiology
- Pharmacogenomics
- Drug abuse
- Evidence based medicine
- Drug addiction
- Drug intolerance
- Antiviral drugs
- Drug interaction
- Telemedicine
- Polypharmacy
- Telepharmacy
- Biological target
- Therapeutic drug monitoring
- Microencapsulation
- Signal transduction
- Drug testing
- Risk management
- Safety monitoring
- Incidence rate
- Drug Utilization Review
- Prescription event monitoring
- Attributable Risk
- Vaccine safety
- Drug adherence
- Relative Risk
- Haematology
- Adverse drug event
- Biopharmaceutical science
- Pharmacoeconomics
- Cost-effectiveness analysis
- Antibiotics
- Probiotics
- Antiretroviral therapy
- Post marketing surveillance
- Clinical research
- Regenerative medication
- Dopamine
- Antidiabetic drugs
- Drug toxicity
- Drug metabolism
- Prodrug
- Clinic management systems
- Drug detoxification
- Pharmaceutical formulation
- Quality assurance
- Validation
- Neuropharmacological study
- Pharmacotherapy
- Medication error
- Translational medication
- Psychoactive drug
- Pharmacognosy
- Pharmacophore
- Drug stability
- Targeted drug delivery
- Drug evaluation
- Quality packing
- Medical guideline
- Over-the-counter medicine
- Prescription writing
- Language barrier for community pharmacist
- Antimicrobial resistance
- Antibiotic prophylaxis
- Community pharmacists
- Health literacy
- Cellular Medicine
- Cell therapy
- Drug Dosage formulation
- Gene therapy
- Genetic polymorphism
- Personalized medicine
- Pharmacogenomic biomarkers
- PROTEOMICS - Clinical Applications
- Drug Efficacy
- Drug Potency
- Clinical audit
- Clinical ethics
- Aquatic toxicology
- Drug safety regulations
- Missed dose
- Medical literature
- Poisonous Effects
- Internal medicine
- Occupational medicine
- Drug overdose
- Postmarketing surveillance
- Premarketing Clinical Trial Safety
- Delayed drug effects
- Automated databases
- Electronic Health Record
- Medical record databases
- Gene-Gene Interaction
- Gene-drug interaction
- Bioethical issues
- Patient Reported Outcome
- White coat adherence
- Drug utilization
- Medical occurrence report
- Pharmaceutical drug
- Prescription drug
- Prescription drug abuse
- Drug addictions
- Drug withdrawal symptoms
- View more